Thomas Senderovitz, SVP of data science at Novo Nordisk, says automation is infiltrating every part of Novo’s clinical trial system, with reports written by AI and not employees. Senderovitz cited the difficulty of working in a regulated industry, but also said the crafting of AI-generated scientific manuscripts is advancing, leading to a future with fewer humans involved in the process.

North Korean Hackers Use Fake U.S. Companies to Spread Malware in Crypto Industry: Report
North Korean hackers reportedly set up shell companies in the US to penetrate the crypto sector and target developers via fake job offers, according to